XML 43 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share
3 Months Ended
Jun. 30, 2013
Earnings Per Share (Thousands of Dollars and Shares Except Per Share Data) [Abstract]  
Earnings Per Share
(2) Earnings Per Share
 
Net earnings per share data for the quarter and six-month periods ended June 30, 2013 and July 1, 2012 were computed as follows:
 
 
 
 
 
 
 
2013
 
 
2012
 
Quarter
 
Basic
 
 
Diluted
 
 
Basic
 
 
Diluted
 
Net earnings
 
$
36,480
 
 
 
36,480
 
 
 
43,427
 
 
 
43,427
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average shares outstanding
 
 
130,323
 
 
 
130,323
 
 
 
130,294
 
 
 
130,294
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Options and other share-based awards
 
 
-
 
 
 
1,657
 
 
 
-
 
 
 
1,824
 
Equivalent Shares
 
 
130,323
 
 
 
131,980
 
 
 
130,294
 
 
 
132,118
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings per common share
 
$
0.28
 
 
 
0.28
 
 
 
0.33
 
 
 
0.33
 
 
 
 
 
 
 
 
2013
 
 
2012
 
Six Months
 
Basic
 
 
Diluted
 
 
Basic
 
 
Diluted
 
Net earnings
 
$
29,809
 
 
 
29,809
 
 
 
40,848
 
 
 
40,848
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average shares outstanding
 
 
129,831
 
 
 
129,831
 
 
 
129,918
 
 
 
129,918
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Options and other share-based awards
 
 
-
 
 
 
1,606
 
 
 
-
 
 
 
1,907
 
Equivalent Shares
 
 
129,831
 
 
 
131,437
 
 
 
129,918
 
 
 
131,825
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings per common share
 
$
0.23
 
 
 
0.23
 
 
 
0.31
 
 
 
0.31
 
 
For the quarters ended June 30, 2013 and July 1, 2012, options and restricted stock unit awards totaling 1,849 and 3,504, respectively, were excluded from the calculation of diluted earnings per share because to include them would have been antidilutive. For the six-month periods ended June 30, 2013 and July 1, 2012, options and restricted stock unit awards totaling 1,511 and 3,523, respectively, were excluded from the calculation of diluted earnings per share because to included them would have been antidilutive.